Previous close | 0.1580 |
Open | 0.1650 |
Bid | 0.1710 x 100 |
Ask | 0.1560 x 100 |
Day's range | 0.1506 - 0.1765 |
52-week range | 0.1200 - 1.5200 |
Volume | |
Avg. volume | 1,961,600 |
Market cap | 2.577M |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.8200 |
Earnings date | 19 Jun 2024 - 24 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Sonoma Pharmaceuticals ( NASDAQ:SNOA ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.14m (up 6.6% from...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu
Sonoma Pharmaceuticals, Inc.'s ( NASDAQ:SNOA ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong...